Stocks / NASDAQ / Paratek Pharmaceuticals, Inc.

Paratek Pharmaceuticals, Inc.

Our Opinion

Paratek Pharmaceuticals is on the Cruelty Free Investing list for exploiting animals because the company does animal testing in developing some of their commercial therapies and clinical analysis.

Supporting Evidence:

The company stated in the following press release that they conduct pre-clinical trials of their drugs on animals.

“To evaluate the microbiological activity of omadacycline in vitro and animal model testing was conducted (Poster #P1325).” Read the following article

Company Description

Paratek Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in novel tetracycline chemistry. Its products include Omadacycline and Sarecycline. The company was founded in February 2001 and is headquartered in Boston, MA. [Source: MarketWatch]

Company Website: